IsoRay

IsoRay Revenue

Delisted

The The revenue of IsoRay (ISR) as of Nov 4, 2026 is 10.80 M USD. In the previous year, The revenue was 10.05 M USD — a change of 7.38% (higher).

Revenue

10.80 MUSD

YoY

7.38%

Last updated:

In 2022, IsoRay's sales reached 10.80 M USD, a 7.38% difference from the 10.05 M USD sales recorded in the previous year.

Revenue has compounded at 11.1% per year over the past 16 years to 10.80 M USD.

The IsoRay Revenue history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
Date
Revenue
Jan 1, 2019
7.31 M USD
Jan 1, 2020
9.68 M USD
Jan 1, 2021
10.05 M USD
Jan 1, 2022
10.80 M USD
Jan 1, 2023 (e)
16.00 M USD
Jan 1, 2024 (e)
23.96 M USD
Jan 1, 2025 (e)
32.62 M USD
Jan 1, 2026 (e)
38.51 M USD
The IsoRay Revenue history
YEARRevenueYoY
est38.51 MUSD+18.07%
est32.62 MUSD+36.13%
est23.96 MUSD+49.75%
est16.00 MUSD+48.22%
10.80 MUSD+7.38%
10.05 MUSD+3.85%
9.68 MUSD+32.35%
7.31 MUSD+23.48%
5.92 MUSD+24.41%
4.76 MUSD-0.17%
4.77 MUSD+3.53%
4.61 MUSD+9.18%
4.22 MUSD-6.76%
4.53 MUSD-10.76%
5.07 MUSD-3.20%
5.24 MUSD-0.89%
5.29 MUSD-2.43%
5.42 MUSD-24.32%
7.16 MUSD+24.76%
5.74 MUSD+187.72%
1.99 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

IsoRay Revenue

IsoRay Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2019
7.31 M USD
-5.28 M USD
-4.85 M USD
Jan 1, 2020
9.68 M USD
-3.48 M USD
-3.27 M USD
Jan 1, 2021
10.05 M USD
-3.44 M USD
-3.20 M USD
Jan 1, 2022
10.80 M USD
-7.39 M USD
-7.15 M USD
Jan 1, 2023 (e)
16.00 M USD
-7.37 M USD
-7.11 M USD
Jan 1, 2024 (e)
23.96 M USD
6.36 M USD
0.00 USD
Jan 1, 2025 (e)
32.62 M USD
6.14 M USD
5.19 M USD
Jan 1, 2026 (e)
38.51 M USD
5.99 M USD
4.75 M USD

IsoRay Margins

IsoRay stock margins

The IsoRay margin analysis displays the gross margin, EBIT margin, as well as the profit margin of IsoRay. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for IsoRay.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2019
41.66 %
-72.16 %
-66.31 %
Jan 1, 2020
52.93 %
-35.91 %
-33.77 %
Jan 1, 2021
50.94 %
-34.19 %
-31.80 %
Jan 1, 2022
42.76 %
-68.47 %
-66.26 %
Jan 1, 2023 (e)
42.76 %
-46.09 %
-44.41 %
Jan 1, 2024 (e)
42.76 %
26.55 %
0.00 %
Jan 1, 2025 (e)
42.76 %
18.83 %
15.92 %
Jan 1, 2026 (e)
42.76 %
15.56 %
12.32 %

IsoRay Stock analysis

What does IsoRay do? The company IsoRay Inc is a leading global company in the field of brachytherapy and specializes in the development of novel medical devices for the treatment of cancer. The company's history dates back to the 1980s when it was founded by a team of doctors and scientists. IsoRay Inc's business model is based on the research, development, and manufacturing of medical products used in the treatment of cancer. Brachytherapy is a particularly important focus. This involves a treatment method where radioactive seeds or sources are directly implanted into the tumor. The radiation destroys the cancer cells without damaging the surrounding tissue. IsoRay Inc's product range includes a variety of medical devices and accessories for conducting brachytherapy procedures. The company specializes in the development of high-tech products that enable precise and effective radiation therapy. This includes, for example, radioactive seeds that are directly implanted into the tumor or apparatuses that can selectively use radiation in specific structures of the body. A special focus of IsoRay Inc is computer-assisted planning of brachytherapy treatments. The tumor is precisely measured and the radiation sources are individually customized based on the data to achieve an optimal radiation dose. This planning is done using modern software and is an important factor for the successful treatment of cancer. In addition to research and development of medical products, IsoRay Inc also encompasses the production and distribution of these products. The company operates in more than 30 countries worldwide and collaborates closely with numerous clinics and practices to research and improve new technologies in the field of radiation therapy. One of IsoRay Inc's most well-known products is the "Cesium-131 Brachytherapy seed." This radioactive seed is particularly small and therefore ideal for targeted radiation therapy of tumors. It is used in almost all clinical areas worldwide and is considered particularly safe and effective. Other products of the company include the "Gladius™ Applicator Needle," a device for precise placement of radiation sources in tumors, as well as "Intraoperative Application Systems" that enable effective radiation therapy during surgery. Overall, IsoRay Inc is considered an innovative and successful company in the field of brachytherapy and radiation therapy. The constant development and improvement of its own products is a key factor for the company's success. High quality and close collaboration with research and practice are central to its operations. IsoRay is one of the most popular companies on Eulerpool.

Revenue Details

Understanding IsoRay's Sales Figures

The sales figures of IsoRay originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing IsoRay’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize IsoRay's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in IsoRay’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about IsoRay stock

The revenue of IsoRay is 10.80 M USD in 2022.

The revenue of IsoRay changed from 10.05 M USD to 10.80 M USD, representing a 7.38% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of The revenue IsoRay since 2006 – with annual values, charts, and detailed analysis.

Revenue is the total value of all goods sold in a period. It is calculated by multiplying the quantity of each product sold by its selling price. Revenue does not include any costs (material costs, personnel costs, etc.), whereas net proceeds only deduct revenue reductions associated with the sale (discounts, etc.).

The revenue's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The revenue's IsoRay historically and in real time.

The revenue in assessing a stock

Revenue is an important financial measure used in the valuation of stocks. It is a measure of a company's economic activity and can serve as an indicator of the company's success. Revenue is considered one of the most important factors in stock valuation. In addition, revenue can also be used to calculate other financial measures such as earnings per share and price-earnings ratio.

History and utilization of revenue

Revenue has long been considered one of the most important financial indicators. It was used in the 19th century as one of the first financial indicators to measure a company's economic activity. Since then, revenue has been regularly used to evaluate companies.

Revenue is usually calculated as a percentage of the company's equity. It can also be used to determine the overall profitability of a company. There are many different types of revenue that can be used to measure a company's economic activity, such as gross revenue, net revenue, and revenue from international business.

The revenue can also be used to evaluate stocks. For example, the revenue of a company can be used to evaluate the success of the company. If a company has high revenue, it means that it is a profitable company because it has high demand for its products or services.

Calculation and Application of Revenue

In order to calculate a company's revenue, the company's income must be deducted from its expenses. The income can come from various sources, such as sales, licensing fees, services, etc. The expenses can include costs for production, procurement, inventory, sales, and administration.

The revenue can then be used to calculate various financial ratios. For example, the revenue can be used to calculate the price-earnings ratio (P/E ratio) of a company. This is a measure of a company's profitability, calculated by taking the ratio of the stock price to earnings per share.

Revenue can also be used to calculate earnings per share (EPS) of a company. This is a measure of a company's profit per share. EPS is calculated by dividing earnings by the number of shares issued.

Use of revenue by investors

Investors use revenue to evaluate stocks, as revenue is an indicator of a company's success. For example, an investor can compare a company's revenue to see how successful it is. An investor can also use a company's revenue to calculate its price-to-earnings ratio and earnings per share.

An example: An investor looks at a company that has a revenue of 25 million euros. He compares this revenue to that of the competitor, which has a revenue of 35 million euros. The investor can then see that the company with 25 million euros in revenue is less successful than the company with 35 million euros in revenue.

Advantages and Disadvantages of Revenue.

Revenue is a very useful tool for valuing stocks as it measures a company's economic activity. Revenue can also be used to calculate other financial ratios such as the price-earnings ratio and earnings per share.

However, one disadvantage is that revenue alone is not a meaningful indicator of a company's success. It is important to consider revenue in comparison to other financial metrics such as earnings per share and price-to-earnings ratio to get a complete picture of the company.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — IsoRay

All Key Metrics — IsoRay